Allogeneic Hematopoietic Stem Cell (HSC) Transplantation

1 clinical trials · Condition

Record	Firm	Date
Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03605953)	Central Hospital, Nancy, France	2018-10-01

Every clearance here is in the API, with alerts when new ones post.